Upgrade to SI Premium - Free Trial

FDA grants priority review to Bayer's Lynkuet for breast cancer use

September 28, 2026 8:00 AM
Bayer announced that the U.S. Food and Drug Administration has accepted a supplemental New Drug Application (sNDA) and granted Priority ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA